75553-8
Comment on fetal Trisomy 13 risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Active
Term Description
This term was developed for, but is not limited in use to, Natera's Panorama noninvasive prenatal test for fetal aneuploidies and microdeletions.
Source: Regenstrief LOINC
Part Descriptions
LP185802-8 Comment on fetal Trisomy 13 risk
Trisomy 13 risk refers to the fetus's risk of having trisomy 13. The risk can be estimated based on maternal age as well as prenatal genetic testing of fetal DNA. Trisomy 13, also called Patau syndrome, is caused by the presence of three copies of chromosome 13 in each cell rather than two. Patau syndrome is associated with severe cognitive delay, various forms of congenital heart disease, brain or spinal cord abnormalities, hypotonia, cleft lip and/or palate, and poorly developed eyes. Many liveborn infants with Patau syndrome die within the first weeks of life, and less than 10% survive longer than one year. The general population risk of Trisomy 13 is about 1 in 16,000 live births, but the risk increases with increasing maternal age. [MedlinePlus Condition: trisomy-13]
Source: Regenstrief LOINC, GHR: Trisomy 13
LP185802-8 Comment on fetal Trisomy 13 risk
The genetic counselor's comment regarding risk of a specific disorder or group of disorders is used to convey follow-up recommendations or other information related to the risk result and interpretation.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Comment on fetal Trisomy 13 risk
- Property
- Txt
- Time
- Pt
- System
- WBC.DNA+Plas.cfDNA
- Scale
- Nar
- Method
- Dosage of chromosome specific cf DNA
Additional Names
- Short Name
- Fet Ts 13 risk comment
- Display Name
- Comment on Trisomy 13 risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
- Consumer Name Alpha Get Info
- Fetal Comment on trisomy 13 risk
Basic Attributes
- Class
- MOLPATH.TRISOMY
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- Release 2.70: COMPONENT: Removed "Genetic counselor" to broaden use since various specialists may provide comments on test results.; Previous Releases: Added "Fetal" to Component to clarify that the result is about the fetus.
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
96978-2 | Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
96977-4 | Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Comentario de consejo genético en riesgo de Trisomía 13: |
es-MX | Spanish (Mexico) | Comentario del asesor genético sobre el riesgo de trisomía 13 fetal: |
fr-FR | French (France) | Risque trisomie 13 foetale (commentaire du conseiller génétique): |
it-IT | Italian (Italy) | Commento su rischio Trisomia 13: Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Rischio di trisomia 13 Testo Trisomia cromosoma genetica |
zh-CN | Chinese (China) | 关于胎儿三体型 13 风险的遗传咨询师意见: Synonyms: WBC.DNA+血浆.cfDNA; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=75553-8
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright